Bank of America
JSPR icon

Bank of America’s Jasper Therapeutics JSPR Stock Holding History

Bank of America’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
293,259
+232
+0.1% +$322 ﹤0.01% 5222
2025
Q4 		$536K Sell
293,027
-1,526
-0.5% -$3.06K ﹤0.01% 4880
2025
Q3 		$701K Buy
294,553
+1,093
+0.4% +$3.31K ﹤0.01% 5567
2025
Q2 		$1.63M Sell
293,460
-67,229
-19% -$331K ﹤0.01% 4936
2025
Q1 		$1.55M Buy
360,689
+73,485
+26% +$489K ﹤0.01% 4896
2024
Q4 		$6.14M Sell
287,204
-38,677
-12% -$805K ﹤0.01% 3390
2024
Q3 		$6.13M Buy
325,881
+557
+0.2% +$11.1K ﹤0.01% 3547
2024
Q2 		$7.38M Buy
325,324
+5,537
+2% +$133K ﹤0.01% 3252
2024
Q1 		$9.39M Buy
319,787
+1,781
+0.6% +$31.6K ﹤0.01% 3037
2023
Q4 		$2.51M Sell
318,006
-24
-0% -$161 ﹤0.01% 4182
2023
Q3 		$2.23M Buy
318,030
+92,820
+41% +$1.13M ﹤0.01% 4141
2023
Q2 		$3.09M Buy
225,210
+47,052
+26% +$699K ﹤0.01% 3831
2023
Q1 		$3.22M Buy
178,158
+178,154
+4,453,850% +$3.29M ﹤0.01% 3945
2022
Q4 		$18 Buy
+4
New +$27 ﹤0.01% 8001
2021
Q3 		– Sell
-11,050
Closed -$1.1M – 8249
2021
Q2 		$1.1M Buy
+11,050
New +$1.1M ﹤0.01% 4827

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Bank of America's JSPR Position: Q1 2026 in Review

Bank of America increased its Jasper Therapeutics (JSPR) stake by 0.08% in Q1 2026, buying an estimated $322 and bringing the position to 293,259 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #5222.

Bank of America first reported a position in JSPR in Q2 2021 and has held it in 15 quarters since. The position peaked at $9.39M in Q1 2024. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Bank of America held 293,259 shares of Jasper Therapeutics worth $257K as of Q1 2026.
  • Bank of America bought 232 Jasper Therapeutics shares in Q1 2026, an estimated $322.
  • Jasper Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5222 holding.
  • Bank of America first reported a position in Jasper Therapeutics in Q2 2021 and has held it in 15 quarters since.
  • Bank of America's Jasper Therapeutics position peaked at $9.39M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.